FDA Elidel
| Date: | Friday January 20, 2006 |
| Type: | Task (Public) |
| Elidel Cream (pimecrolimus) Protopic Ointment (tacrolimus) Audience: Dermatological and other healthcare professionals [Posted 01/20/2006] The Food and Drug Administration announced the approval of updated labeling for two topical eczema drugs, Elidel Cream (pimecrolimus) and Protopic Ointment (tacrolimus). The labeling will be updated with a boxed warning about a possible risk of cancer and a Medication Guide (FDA-approved patient labeling) will be distributed to help ensure that patients using these prescription medicines are aware of this concern. The new labeling also clarifies th |
 |